The mRNA expression levels of GABA_A receptor α1 and α2 subunits in patients with major depressive disorder during onset and remission

References

• Collins PY, Insel TR, Chockalingam A, et al. Grand challenges in global mental health: integration in research, policy, and practice. PLoS Med. 2013;10(4):e1001434.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105.
   PubMed Web of Science ®Google Scholar
• Chiriţă AL, Gheorman V, Bondari D, et al. Current understanding of the neurobiology of major depressive disorder. Rom J Morphol Embryol. 2015;56(2 Suppl):651–658.
   PubMed Web of Science ®Google Scholar
• Levinson AJ, Fitzgerald PB, Favalli G, et al. Evidence of cortical inhibitory deficits in major depressive disorder. Biol Psychiatry. 2010;67(5):458–464.
   PubMed Web of Science ®Google Scholar
• Charych EI, Liu F, Moss SJ, et al. GABA(a) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders. Neuropharmacology. 2009;57(5-6):481–495.
   PubMed Web of Science ®Google Scholar
• Woo HI, Chun MR, Yang JS, et al. Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors. CNS Neurosci Ther. 2015;21(5):417–424.
   PubMed Web of Science ®Google Scholar
• Mauri MC, Ferrara A, Boscati L, et al. Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology. 1998;37(3):124–129.
   PubMed Web of Science ®Google Scholar
• Garakani A, Martinez JM, Yehuda R, et al. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment. J Affect Disord. 2013;146(2):262–265.
   PubMed Web of Science ®Google Scholar
• Zhao J, Verwer RWH, Gao SF, et al. Prefrontal alterations in GABAergic and glutamatergic gene expression in relation to depression and suicide. J Psychiatr Res. 2018;102:261–274.
   PubMed Web of Science ®Google Scholar
• Ghosal S, Hare BD, Duman RS. Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression. Curr Opin Behav Sci. 2017;14:1–8.
   PubMed Web of Science ®Google Scholar
• Hasler G, van der Veen JW, Tumonis T, et al. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2007;64(2):193–200.
   PubMed Web of Science ®Google Scholar
• Price RB, Shungu DC, Mao X, et al. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry. 2009;65(9):792–800.
   PubMed Web of Science ®Google Scholar
• Schur RR, Draisma LW, Wijnen JP, et al. Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of (1) H-MRS studies. Hum Brain Mapp. 2016;37(9):3337–3352.
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Folsom TD, Kneeland RE, et al. Impairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched protein tyrosine phosphatase, and homer 1, in autism: a postmortem study in cerebellar vermis and superior frontal cortex. Mol Autism. 2013;4(1):21.
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Reutiman TJ, Folsom TD, et al. Downregulation of GABAA receptor protein subunits α6, β2, δ, ε, γ2, θ, and ρ2 in superior frontal cortex of subjects with autism. J Autism Dev Disord. 2014;44(8):1833–1845.
   PubMed Web of Science ®Google Scholar
• Glausier JR, Lewis DA. Selective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology. 2011;36(10):2103–2110.
   PubMed Web of Science ®Google Scholar
• Fatemi SH, Folsom TD, Rooney RJ, et al. Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry. 2013;3(9):e303.
   PubMed Web of Science ®Google Scholar
• Vollenweider I, Smith KS, Keist R, et al. Antidepressant-like properties of α2-containing GABA(A) receptors. Behav Brain Res. 2011;217(1):77–80.
   PubMed Web of Science ®Google Scholar
• Bhandage AK, Jin Z, Hellgren C, et al. AMPA, NMDA and kainate glutamate receptor subunits are expressed in human peripheral blood mononuclear cells (PBMCs) where the expression of GluK4 is altered by pregnancy and GluN2D by depression in pregnant women. J Neuroimmunol. 2017;305:51–58.
   PubMed Web of Science ®Google Scholar
• Bhandage AK, Hellgren C, Jin Z, et al. Expression of GABA receptors subunits in peripheral blood mononuclear cells is gender dependent, altered in pregnancy and modified by mental health. Acta Physiol (Oxf)). 2015;213(3):575–585.
   PubMed Web of Science ®Google Scholar
• Portella MJ, de Diego-Adeliño J, Gómez-Ansón B, et al. Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. J Psychiatr Res. 2011;45(4):427–434.
   PubMed Web of Science ®Google Scholar
• Bradley KA, Alonso CM, Mehra LM, et al. Elevated striatal γ-aminobutyric acid in youth with major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2018;86:203–210.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, O'Dwyer G, Teleki Z, et al. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology. 2007;32(2):471–482.
   PubMed Web of Science ®Google Scholar
• Maciag D, Hughes J, O'Dwyer G, et al. Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol Psychiatry. 2010;67(5):465–470.
   PubMed Web of Science ®Google Scholar